Trial · NCT03805750
Results by group74
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 74
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Digital Spirography | CBD/THC | 1.04 | Standard Deviation 0.57 | millimeters of tremor amplitude | |
| Digital Spirography | Placebo | 1.00 | Standard Deviation 0.42 | millimeters of tremor amplitude | |
| Change in Score on a Scale From Baseline of the Tremor Research Group Essential Tremor Rating Scale (TETRAS) | CBD/THC | -8.07 | Standard Deviation 5.71 | score on a scale | |
| Change in Score on a Scale From Baseline of the Tremor Research Group Essential Tremor Rating Scale (TETRAS) | Placebo | -10.3 | Standard Deviation 3.9 | score on a scale | |
| Global Impression of Change | CBD/THC | Clinical Global Impression of Change | 3 | Full Range 3 to 4 | score on a scale |
| Global Impression of Change | Placebo | Clinical Global Impression of Change | 4 | Full Range 2 to 4 | score on a scale |
| Global Impression of Change | CBD/THC | Patient Global Impression of Change | 3 | Full Range 3 to 4 | score on a scale |
| Global Impression of Change | Placebo | Patient Global Impression of Change | 4 | Full Range 2.5 to 4 | score on a scale |
| Number of Participants Reporting Adverse Events Based on Common Terminology Criteria | CBD/THC | Ringing in ears | 7 | Participants | |
| Number of Participants Reporting Adverse Events Based on Common Terminology Criteria | Placebo | Ringing in ears | 6 | Participants | |
| Number of Participants Reporting Adverse Events Based on Common Terminology Criteria | CBD/THC | Numbness/tingling | 4 | Participants | |
| Number of Participants Reporting Adverse Events Based on Common Terminology Criteria | Placebo | Numbness/tingling | 4 | Participants | |
| Number of Participants Reporting Adverse Events Based on Common Terminology Criteria | CBD/THC | Dyspnea on exertion | 4 | Participants | |
| Number of Participants Reporting Adverse Events Based on Common Terminology Criteria | Placebo | Dyspnea on exertion | 4 | Participants | |
| Number of Participants Reporting Adverse Events Based on Common Terminology Criteria | CBD/THC | Watery eyes | 3 | Participants | |
| Number of Participants Reporting Adverse Events Based on Common Terminology Criteria | Placebo | Watery eyes | 3 | Participants | |
| Number of Participants Reporting Adverse Events Based on Common Terminology Criteria | CBD/THC | Runny nose | 3 | Participants | |
| Number of Participants Reporting Adverse Events Based on Common Terminology Criteria | Placebo | Runny nose | 2 | Participants | |
| Number of Participants Reporting Adverse Events Based on Common Terminology Criteria | CBD/THC | Decreased concentration | 7 | Participants | |
| Number of Participants Reporting Adverse Events Based on Common Terminology Criteria | Placebo | Decreased concentration | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03805750/results